榮昌生物-B(09995.HK)澄清與A股發售招股章程相關報道失實
榮昌生物-B(09995.HK)發澄清公告,於去年12月31日注意到多個媒體平臺發佈了一則新聞報道,其中提及公司建議A股發售的招股章程並載有若幹涉及公司的指稱,該報道所作指稱毫無根據且該報道含有多項失實陳述、虛假指稱和明顯的事實錯誤。
其中,公司指該報道宣稱公司已與若幹關聯方訂立若幹借款,惟6億元人民幣(下同)的差異並無披露於公司截至2019年12月31日止年度財務報表的年末結餘及A股招股章程的其他部分。公司迴應稱所謂6億元的差異,公司已在A股招股章程「關聯方交易」及「歷史及發展」等節以及公司日期爲2020年10月28日的招股章程附錄腳註作出清楚的解釋。差異是由於公司於2019年6月與榮昌製藥訂立增資協議所致,根據增資協議,煙臺榮昌製藥股份給公司提供的金額爲6億元的借款將被資本化並轉爲公司資本。
公司強調報道的指稱均無根據,否認該報道所述的指稱,並已尋求法律意見,將在必要時採取一切法律措施保護權利。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.